Autopsy report · NCT02065323

A Study of Dovitinib With Androgen Deprivation Therapy (ADT) in Patients With Metastatic Prostate Cancer Receiving Primary ADT

“Terminated due to budgetary considerations and length of development.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Phase 2

Sponsor

Oscar Goodman, Jr.

Sponsor type

University, hospital or other

Conditions

Prostate Cancer

Interventions

Standard ADT; Dovitinib

Participants

0

Sites

1

Countries

United States

Trials that died the same way

• Physician's Comfort Level and Satisfaction Study With The e2TM Collector Compared to the Spatula/CytoBrush Technique
  “Terminated for lack of resources to complete.” (72% match in meaning)
• Auricular Point Acupressure: Examining the Scientific Underpinnings of Pain Relief
  “Funding duration ended.” (68% match in meaning)
• Observational Biologic or Prosthetic Mesh
  “Premature termination due to cease of funding” (68% match in meaning)
• KSD-201 Treatment for Advanced Clear Cell Renal Cell Carcinoma: an Early Exploratory Clinical Study
  “Due to a strategic adjustment, the company has decided to terminate the project.” (67% match in meaning)
• A Study to Evaluate the Efficacy and Safety of Abiprubart in Participants With Sjögren's Disease
  “Terminated due to strategic business decision.” (66% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.